# GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial

> **NCT03506113** · PHASE4 · COMPLETED · sponsor: **Osaka General Medical Center** · enrollment: 206 (actual)

## Conditions studied

- Ventilator Associated Pneumonia

## Interventions

- **DRUG:** Gram stain-guided antibiotic choice
- **DRUG:** Guidelines-based antibiotics choice

## Key facts

- **NCT ID:** NCT03506113
- **Lead sponsor:** Osaka General Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2020-06-28
- **Final completion:** 2020-06-28
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2022-09-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03506113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03506113, "GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03506113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*